New Partnership Brings Innovative Single Cell Solutions to Researchers Across Japan SEATTLE — Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Tokyo-based SCRUM Inc. to expand its presence in Japan’s research community. This collaboration will provide researchers in academia and industry with full access to Parse’s […]
Akoya’s technology to generate data for a first-of-its-kind Biobank and Data Repository for Cancer Equity Research, funded through the Cancer Grand Challenges initiative The unprecedented scale of the initiative requires the high plex and high throughput of Akoya’s PhenoCycler-Fusion platform to process thousands of patients’ samples MARLBOROUGH, Mass. — Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial […]
Stratyx™ 250 is an innovative new bioreactor system from Culture Biosciences that accelerates bioprocess development, reduces costs and provides real-time remote control and monitoring for teams working on applications ranging from cell line development to protein expression. SOUTH SAN FRANCISCO, Calif. — Culture Biosciences, a leader in cloud-based biomanufacturing, announced the launch of Stratyx™ 250, the first […]
Limula appoints cell therapy expert, Dr. Jonathan Esensten, to its Strategic Advisory Board. The appointment supports the development of LimONE, Limula’s integrated platform for automated cell and gene therapy (CGT) manufacturing. Lausanne, Switzerland – Limula, an emerging life science tools company specializing in automated Cell and Gene Therapy manufacturing solutions, has appointed Dr. Jonathan Esensten to […]
Mr. Jeffrey Gatz Brings Track Record of Growing companies and expertise in the Life Science Tools spaceg. WEST SACRAMENTO, Calif. — Gemini Bioproducts, LLC (“GeminiBio”), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Fort Lauderdale-based healthcare private equity firm, announced today the appointment of Jeffrey Gatz to its […]
Following a successful Korea launch, MEPSGEN brings advanced microfluidic technology to U.S. researchers NanoCalibur™ offers precise, scalable, and reproducible nanoparticle production for drug development MEPSGEN’s CEO to present new technology at the 4th LNP Formulation & Process Development Summit, on April 15, in Boston. BOSTON — MEPSGEN US Inc., a global innovator in scalable nanoparticle production technology, announced today the launch of NanoCalibur™, a […]
First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and cell viability of monoclonal antibody producing cells Cambridge, UK: Sphere Bio, a leading provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, today announced the launch […]
Bethlehem, PA — ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform poised to transform cell expansion for Advanced Therapy Medicinal Products (ATMPs). Designed to overcome the limitations of currently available systems, the ATB™ delivers unprecedented process control and scalability from […]
Bethlehem, PA – ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform poised to transform cell expansion for Advanced Therapy Medicinal Products (ATMPs). Designed to overcome the limitations of currently available systems, the ATB™ delivers unprecedented process control and scalability from bench […]
FARMINGDALE, N.Y. — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quoted on the OTCQX Best Market (“OTCQX”). Enzo provided notice of the voluntary delisting to the NYSE on March 28, […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
